P
MRK icon

Palladiem’s Merck MRK Stock Holding History

Palladiem’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28K Hold
10
– – ﹤0.01% 127
2026
Q1 		$1.21K Hold
10
– – ﹤0.01% 144
2025
Q4 		$1.05K Buy
+10
New +$939 ﹤0.01% 157
2015
Q2 		– Sell
-2,164
Closed -$119K – 261
2015
Q1 		$119K Sell
2,164
-105
-5% -$5.95K 0.1% 33
2014
Q4 		$123K Buy
+2,269
New +$126K 0.1% 41

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Palladiem's MRK Position: Q2 2026 in Review

Palladiem held its Merck (MRK) position steady in Q2 2026 at 10 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #127.

Palladiem first reported a position in MRK in Q4 2014 and has held it in 5 quarters since. The position peaked at $123K in Q4 2014. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Palladiem held 10 shares of Merck worth $1.28K as of Q2 2026.
  • Palladiem left its Merck share count unchanged in Q2 2026.
  • Merck made up ﹤0.01% of Palladiem's portfolio in Q2 2026, its #127 holding.
  • Palladiem first reported a position in Merck in Q4 2014 and has held it in 5 quarters since.
  • Palladiem's Merck position peaked at $123K in Q4 2014.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Palladiem's 13F filing for Q2 2026, filed 13 Aug 2026.